9,10-dimethyl-1,2-benzanthracene and Hypercalcemia

9,10-dimethyl-1,2-benzanthracene has been researched along with Hypercalcemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horiuchi, R; Iino, Y; Ishikita, T; Maemura, M; Morishita, Y; Ohwada, S; Sugamata, N; Yokoe, T; Yoshida, M	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Hypercalcemia

Article	Year
1 alpha-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Breast cancer research and treatment, 1992, Volume: 22, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Female; Fluorouracil; Hydroxycholecalciferols; Hypercalcemia; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Rats; Rats, Sprague-Dawley; Weight Loss	1992

Article

Year

1 alpha-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

Breast cancer research and treatment, 1992, Volume: 22, Issue:2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Female; Fluorouracil; Hydroxycholecalciferols; Hypercalcemia; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Rats; Rats, Sprague-Dawley; Weight Loss

1992